Why the gut.
Why daily.
Why now.
A plain-language explanation of what Yogutide is designed to do — and the published, peer-reviewed research behind it, with every source linked so you can read it yourself.
Metabolic disease is slow, quiet, and starts in the gut.
The decade before the diagnosis is where it is quietly decided.
Type 2 diabetes. Metabolic syndrome. Chronic inflammation. These are not events — they are the slow accumulation of thousands of small daily inputs that tip a biological system over a threshold, usually over the course of ten to twenty years. By the time most people receive a diagnosis, the underlying condition has been building for a long time.
The gut microbiome — the ecosystem of bacteria that lives in your intestine — is one of the most significant determinants of how your metabolism functions. It regulates how efficiently you process nutrients, how readily you produce satiety hormones, how much systemic inflammation your body carries, and how well your immune system responds to ordinary stressors. And it is shaped, more than almost any other factor, by what you eat and drink every day.
This is not new knowledge. What is missing is not research — it is a daily product that makes acting on that research practical, pleasurable, and consistent. That is the gap Yogutide is designed to fill.
The best time to support your metabolic health is twenty years before you need to. The second best time is now.Yogutide · First Principle
GLP-1: the hormone your body already makes.
Not a drug that supplies it from outside. A daily input that supports it from within.
Glucagon-like peptide-1 — GLP-1 — is a hormone produced by enteroendocrine cells in the small intestine and colon. Its primary role is to signal satiety: it tells your brain that you have eaten enough, slows gastric emptying to extend the feeling of fullness, and modulates insulin release in response to food. You have probably read about GLP-1 in the context of drugs like semaglutide. Those drugs are synthetic mimics — they supply GLP-1 from the outside. Yogutide is designed to work differently: to support your body's own production of GLP-1 through the gut microbiome, naturally, every day.
Specific probiotic strains and prebiotic fibres are shown in peer-reviewed literature to support GLP-1 secretion by increasing the population of short-chain fatty acid-producing bacteria, which in turn stimulate L-cells to produce more GLP-1. This is not a drug effect — it is a dietary effect. The same kind of effect a traditionally fermented diet has produced for thousands of years, made more consistent and more targeted.
Food noise is the relentless background chatter about eating — the mid-morning craving, the 3pm pull toward the fridge, the decision fatigue that builds through the day. When GLP-1 is supported consistently, that signal quiets. Not through willpower or restriction — through the biology that was always supposed to be running this.
Every decision has a cognitive cost, and decisions about food are among the most frequent we make. When food noise quiets, that mental bandwidth returns: better focus through the morning, longer stretches of uninterrupted thinking, more capacity for the things that actually matter. Metabolic clarity is a primary design goal, not a side effect.
The gut microbiome does not only regulate digestion. It influences systemic inflammation, immune function, energy metabolism, and mood. A consistent daily probiotic and prebiotic input does not fix one symptom — it shifts the baseline everything else operates from. This is what preventive health looks like before it becomes necessary.
What happens when you drink it daily.
The microbiome responds to consistency, not to a single can.
One can per day — or every other day at minimum — is where the effect becomes measurable and compounds over time. Here is what that typically looks like, in people whose gut microbiome responds to it.
The live probiotic cultures are introduced to your gut environment. The taste experience is the primary signal — sparkling, tangy, satisfying. No dramatic changes yet; the microbiome does not shift overnight.
As cultures begin to establish, some people notice mild digestive adjustment — minor bloating or changes in regularity. This is normal and typically resolves within the first week. A number of people will not notice it at all.
Many people report reduced cravings between meals and improved satiety after eating — a quieter morning, less pull toward snacking. Individual responses vary; the shift is gradual, and not everyone notices a change in the first two weeks.
The morning ritual is established. For those noticing an effect, satiety tends to feel more consistent by this point, and some report steadier energy through the afternoon. The microbiome is stabilising around the new daily input.
Those who report the most change describe it this way: quieter hunger, steadier energy, less friction around food. Not dramatic — a quieter baseline. Yogutide is not a quick fix. It is a daily input designed to produce a different output over time.
What is in WonderFULL.
A short ingredient list is a choice, not a limitation.
Every ingredient is there for a specific, documented reason. Nothing is in the can for marketing purposes — and what is deliberately left out matters as much as what is in.
Support gut microbiome diversity. Selected strains associated with short-chain fatty acid production and GLP-1 stimulation.
Feeds the probiotic cultures and supports colonisation. Provides the substrate for SCFA production — the upstream trigger for GLP-1 secretion.
Naturally fermented dairy. The vehicle for the cultures, contributing lactic acid bacteria that support the gut environment.
Sugar disrupts the gut environment and counteracts the metabolic purpose of the drink. What is not in the can matters as much as what is.
The research we built on — in plain language.
Independent, peer-reviewed, and linked so you can check it yourself.
Everything below is publicly available research published in independent scientific journals — we didn't fund any of it, and we've linked every source so you can read it yourself. We've translated each finding into plain English and noted what it means for what we're building.
Most of this research is about the underlying science our product is built on, not trials of Yogutide itself. That's an honest distinction, and we'd rather you hear it from us. As we run our own studies, this page will grow.
Each one published in an independent journal and cited below.
Pooled across the human trials and meta-analyses referenced here.
None of it funded by us. All of it open for you to read.
Your gut quietly runs your metabolism.
Decades of research point to one place where metabolic health is won or lost — long before any symptom appears.
Fibre is food for your gut bacteria — and the fuel for everything downstream.
The fibre we can't digest is fermented by gut bacteria into beneficial compounds that influence body weight, inflammation, and how the body handles sugar. Modern diets are low in this kind of fibre, and that shortfall reshapes the microbiome for the worse.
Yogutide is built to put that missing fibre back — deliberately, in a form your gut bacteria can use, every day.
Makki, Deehan, Walter & Bäckhed · Cell Host & Microbe, 2018 Source ↗
People who eat the way humans evolved to eat have richer, more diverse gut microbiomes.
When researchers studied the Hadza — one of the last hunter-gatherer communities — they found far greater microbial diversity than in city-dwelling populations: the kind of gut ecosystem associated with long-term metabolic resilience.
It's a picture of the diverse, well-fed gut we're trying to help you rebuild — through a modern daily ritual rather than a return to foraging.
Schnorr, Candela, Rampelli et al. · Nature Communications, 2014 Source ↗
The same communities show almost none of the metabolic disease we treat as inevitable.
Across their lives, these populations show very low rates of the cardiovascular and metabolic risk factors that become common with age in the modern world — a reminder of how much of it traces back to how we live, move, and eat.
A reminder of why small daily inputs, sustained over years, matter more than any quick fix — the principle Yogutide is designed around.
Raichlen, Pontzer, Harris et al. · American Journal of Human Biology, 2017
How fibre becomes a natural satiety signal.
This is the chain of events the product is designed to support — and scientists have mapped it in detail.
The compounds gut bacteria make can switch on your body's own satiety hormones.
Short-chain fatty acids — the byproducts of fibre fermentation — triggered the release of appetite-regulating hormones, including GLP-1, and protected against weight gain on a rich diet. Importantly, the effect worked through more than one pathway, which makes it robust.
This is the natural pathway behind Yogutide: supporting the GLP-1 your body already makes, rather than supplying it from the outside like a drug.
Lin, Frassetto, Kowalik et al. · PLOS ONE, 2012 Source ↗
When these compounds go up, the body handles insulin better.
Pooling 23 human studies, researchers found that raising short-chain fatty acids was linked to improved insulin sensitivity — one of the earliest, quietest markers of metabolic health, long before anything shows up at a check-up.
Exactly the kind of upstream, preventive improvement Yogutide aims to support — gently, over time.
Pham, Joglekar, Wong et al. · Nutrition Reviews, 2024 Source ↗
Feeding your gut bacteria changes how many calories your body actually absorbs.
In a carefully controlled clinical trial, a diet designed to feed the microbiome led people to absorb measurably fewer calories — without eating less, and without feeling hungrier. The difference showed up in the science, not in willpower.
Some of the strongest human evidence for the idea at the heart of Yogutide: support the gut well, and the rest tends to follow.
Corbin, Carnero, Dirks et al. · Nature Communications, 2023 Source ↗
What this actually does in real people.
Across many thousands of people, these interventions move the needle — modestly, but consistently. We think honesty about "modestly" is what makes the rest believable.
Across 200 studies and 12,000+ people, probiotics nudged weight, waistline and body fat down.
One of the largest analyses of its kind found small but consistent improvements in body weight, waist circumference and body fat from probiotic and fibre-plus-probiotic supplements. No single study was dramatic — the consistency across so many is what matters.
We're upfront that the effects are gentle. Yogutide is daily support, not a drug — and consistency, not intensity, is the whole point.
Saadati, Naseri, Asbaghi et al. · Obesity Reviews, 2024 Source ↗
The same kinds of supplements improved blood-sugar markers in people managing diabetes.
Pooling 41 clinical trials, researchers saw improvements in long-term blood sugar, fasting glucose and insulin — and found that blends of several strains worked better than single strains.
Evidence that the category supports healthy blood sugar — and a strong hint that a thoughtful multi-strain blend is worth the effort.
Baroni, Fabrizi, Luciani et al. · Clinical Nutrition, 2024
The most recent, most careful review confirms the direction — and stays honest about the limits.
Across 87 trials, probiotics were linked to more beneficial gut bacteria and to reductions in weight and body fat, with effects building over four weeks or more. The authors are candid that responses vary from person to person.
It's why we say "daily, for at least a month" — and why we never promise you a specific number.
Lee, Akan, Önel et al. · Obesity Reviews, 2025
A defined probiotic blend reversed the gut damage caused by a poor diet.
In a controlled study, a specific blend of beneficial bacteria slowed weight gain and restored the healthy gut bacteria that a high-fat, high-sugar diet had stripped away.
Proof of principle that the right cultures, at the right dose, can shift the gut back toward balance.
Kong, Gao, Yan, Huang & Qin · Nutrition, 2019 Source ↗
Which strains and fibre actually matters.
Not all probiotics are equal. The science of which strains do what is exactly where careful formulation begins.
Scientists screened dozens of strains to find the ones that turn fibre into the good stuff.
Out of 86 candidate strains, researchers identified the specific ones that thrive on prebiotic fibre and produce the most beneficial short-chain fatty acids — including several "butyrate producers" documented for the first time.
The kind of evidence that guides serious strain selection. We don't cut corners here — and we keep our exact blend to ourselves.
Renye, White et al. · Microorganisms, 2021 Source ↗
Pairing the right fibre with the right culture measurably boosts both growth and benefit.
Food scientists showed that matching a probiotic strain with the right prebiotic fibre maximises how well the culture grows and how much beneficial acid it produces — the two don't work as well apart.
It's why Yogutide is a synbiotic: culture and fibre chosen to work together, not just dropped into the same can.
Liong & Shah · Journal of Food Science, 2005
Every study above is independent of Yogutide and freely available — we've linked the sources so you can read them yourself. Most of this research is about the underlying science our product is built on, not trials of Yogutide itself. That's an honest distinction, and we'd rather you hear it from us. As we run our own studies, this page will grow.
What we can and cannot claim.
We are scientists. We would rather be precise than persuasive.
Under EU Regulation 1924/2006, health claims on food products must be authorised and specific. We have written this page to reflect the current state of the science — not to overstate it, and not to hide behind vague language either. All statements have not been evaluated by the Food and Drug Administration (or European analogue). This product is not intended to diagnose, treat, cure or prevent any disease.
Well-established across a large body of peer-reviewed research. Specific strains have known effects on gut barrier integrity, immune modulation, and metabolic function.
Mechanistically well-understood. SCFA production by gut bacteria is a known upstream trigger of GLP-1 release from L-cells. This is the pathway Yogutide is designed to support.
Microbiome composition differs significantly between people, and the magnitude of effect from any probiotic intervention varies. Some notice more change than others. We do not promise a specific outcome — we support a known biological pathway.
Yogutide is a functional food, not a drug or treatment, and not a substitute for medical advice. If you have a diagnosed metabolic condition, speak to your doctor. We are making the daily input better — not replacing clinical care.